Trials / Completed
CompletedNCT02326090
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
A Phase 2, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1.0% and 2.5% Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 161 (actual)
- Sponsor
- Herantis Pharma Plc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the Phase 2 study is to compare the safety and efficacy of cis-UCA Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cis-UCA ophthalmic solution 1.0% | |
| DRUG | cis-UCA ophthalmic solution 2.5% | |
| DRUG | Placebo ophthalmic solution |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-12-25
- Last updated
- 2015-09-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02326090. Inclusion in this directory is not an endorsement.